|
Market Cap (2-Jul) $12,281,100 (923rd) |
Close (30-Jun) $0.125 |
Volume (30-Jun) 0 |
Shortsold (17-Apr) 8,415 (0.00%) (600th) |
|
52w High $0.058 |
52w Low $0.021 |
P/E - |
EPS -0.004 |
EMD released this announcement to the ASX on 23 February 2023, 17:09. The announcement is not marked as price sensitive, and is 15 page(s) in length and 395.42kb in size.
You can view all announcements from EMD and see how they appear on a price chart on the announcements page.
At the date of this announcement, EMD was 0.086% short sold according to ASIC data. It was ranked the 470th most shorted stock on the ASX. It remains ranked 600th as of the latest reported data (17 April 2025).
| Other Recent Announcements from EMD | |
|---|---|
| Trading Halt | 29 June 2023, 9:33 |
| Emyria Receives Ethics Approval for MDMA-assisted Therapy | 8 June 2023, 9:10 |
| Section 708A(5)(e) Notice | 10 May 2023, 18:37 |
| Change of Director's Interest Notice x 5 | 23 February 2023, 17:09 |
| Notification regarding unquoted securities - EMD | 23 February 2023, 17:06 |
| Application for quotation of securities - EMD | 23 February 2023, 17:03 |
| Emyria secures clinical-grade MDMA supply for Aust patients | 13 February 2023, 9:33 |
You must be logged in to post a reply.
Emyria 